Life ScienceCompany
Assembly Biosciences - Clinical-Stage M201 Program Ownership
Who owns Assembly Biosciences - Clinical-Stage M201 Program?
Assembly Biosciences - Clinical-Stage M201 Program is owned by Xbiome. It was acquired on April 25, 2022.
Assembly Biosciences - Clinical-Stage M201 Program Business Overview
Where is Assembly Biosciences - Clinical-Stage M201 Program headquartered?
Assembly Biosciences - Clinical-Stage M201 Program is headquartered in San Francisco, California.
What sector is Assembly Biosciences - Clinical-Stage M201 Program in?
Assembly Biosciences - Clinical-Stage M201 Program is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.